Lindsay A. Rosenwald is an American doctor, biotechnology and life sciences industry investor.[1] He is the co-founder of the healthcare private equity firm Opus Point Partners.[2] Rosenwald has created and sold several biotechnological companies. In 2013 he established Fortress Biotech.[3]
Medicines his companies developed have been approved by the United States Food and Drug Administration as well as in foreign countries, such as Mexico or Canada. One medicine was approved for acute promyelocytic leukemia, a routinely fatal disease. This medicine has cured many thousands of incurable patients over the last decade, marking a significant change to how this disease is treated. One of his start-ups also developed a prostate cancer medicine. That company acquired $1 billion after Phase 2 studies.[4] Other approved medicines include meds for schizophrenia, fibromyalgia, obesity, influenza, and infant respiratory distress syndrome.